According to Dermapharm's latest financial reports the company has a price-to-book ratio of 3.16.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 4.37 | 14.02% |
2022-12-31 | 3.84 | -60.04% |
2021-12-31 | 9.60 | 0.96% |
2020-12-31 | 9.51 | 25.2% |
2019-12-31 | 7.59 | 61.08% |
2018-12-31 | 4.71 | |
2017-12-31 | N/A | |
2016-12-31 | N/A |